Sansure Biotech Inc. (688289.SS)
CNY 22.2
(0.0%)
CNY 22.2
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 376.63 Million CNY | 6.0% |
| 2022 | 355.31 Million CNY | -3.84% |
| 2021 | 369.5 Million CNY | 33.52% |
| 2020 | 276.73 Million CNY | 327.96% |
| 2019 | 64.66 Million CNY | 15.68% |
| 2018 | 55.89 Million CNY | 36.77% |
| 2017 | 40.87 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 419.03 Million CNY | 6.9% |
| 2024 Q1 | 385.49 Million CNY | 2.35% |
| 2024 Q2 | 391.96 Million CNY | 1.68% |
| 2023 Q4 | 376.63 Million CNY | 11.95% |
| 2023 FY | 376.63 Million CNY | 6.0% |
| 2023 Q3 | 336.42 Million CNY | -0.93% |
| 2023 Q1 | 346.72 Million CNY | -2.42% |
| 2023 Q2 | 339.57 Million CNY | -2.06% |
| 2022 Q3 | 555.99 Million CNY | -1.48% |
| 2022 Q2 | 564.33 Million CNY | 22.35% |
| 2022 Q1 | 461.24 Million CNY | 24.83% |
| 2022 FY | 355.31 Million CNY | -3.84% |
| 2022 Q4 | 355.31 Million CNY | -36.09% |
| 2021 Q4 | 369.5 Million CNY | -15.27% |
| 2021 Q2 | 402.77 Million CNY | -18.72% |
| 2021 Q1 | 495.52 Million CNY | 79.06% |
| 2021 Q3 | 436.07 Million CNY | 8.27% |
| 2021 FY | 369.5 Million CNY | 33.52% |
| 2020 Q3 | 230.06 Million CNY | 26.57% |
| 2020 Q4 | 276.73 Million CNY | 20.29% |
| 2020 Q2 | 181.77 Million CNY | 77.72% |
| 2020 Q1 | 102.28 Million CNY | 58.18% |
| 2020 FY | 276.73 Million CNY | 327.96% |
| 2019 Q4 | 64.66 Million CNY | 0.0% |
| 2019 FY | 64.66 Million CNY | 15.68% |
| 2019 Q1 | - CNY | 0.0% |
| 2018 FY | 55.89 Million CNY | 36.77% |
| 2017 FY | 40.87 Million CNY | 0.0% |